CD8A and COVID-19: In vitro studies have shown that Tα1 could mitigate cytokine expression and inhibit lymphocyte activation in a CD8+ T-cell subset from COVID-19 patients, which suggest that the potential role of Tα1 in modulating the immune response homeostasis and the cytokine storm in vivo (32).